CSIMarket
 


Immuron Limited  (IMRN)
Other Ticker:  
 

Immuron Limited's Leverage Ratio

IMRN's quarterly Leverage Ratio and Total Liabilities, Equity growth




IMRN Leverage Ratio (Jun 30 2021)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2020)
IV. Quarter
Y / Y Equity Change 358.81 % 358.81 % 358.81 % 358.81 % -23.22 %
Y / Y Total Liabilities Change 107.44 % 107.44 % 107.44 % 107.44 % -53.88 %
Leverage Ratio MRQ 0.04 0.04 0.04 0.04 0.1
Overall Ranking # 157 # 0 # 0 # 0 # 0
Seq. Equity Change 0 % 0 % 0 % 358.81 % 0 %
Seq. Total Liabilities Change 0 % 0 % 0 % 107.44 % 0 %



Leverage Ratio forth quarter 2021 Comment
Due to repayements of liabilities of 0% Immuron Limited improved Leverage Ratio in forth quarter 2021 to 0.04, a new company low.

Within Major Pharmaceutical Preparations industry in the forth quarter 2021, 45 other companies have achieved lower Leverage Ratio than Immuron Limited. While Leverage Ratio total ranking has deteriorated compare to the previous quarter from 0 to 157.

Explain Leverage Ratio?
Who are IMRN Customers?
Leverage Ratio forth quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 46
Healthcare Sector # 71
Overall Market # 157


Leverage Ratio Statistics
High Average Low
0.16 0.1 0.04
(Jun 30 2019)   (Jun 30 2021)




Financial Statements
Immuron Limited's Equity $ 26 Millions Visit IMRN's Balance sheet
Immuron Limited's Total Liabilities $ 1 Millions Visit IMRN's Balance sheet
Source of IMRN's Sales Visit IMRN's Sales by Geography


Cumulative Immuron Limited's Leverage Ratio

IMRN's Leverage Ratio for the trailling 12 Months

IMRN Leverage Ratio

(Jun 30 2021)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2020)
IV. Quarter
Y / Y Equity TTM Growth 358.81 % 358.81 % 358.81 % 358.81 % -23.22 %
Y / Y Total Liabilities TTM Growth 107.44 % 107.44 % 107.44 % 107.44 % -53.88 %
Leverage Ratio TTM 0.04 0.05 0.05 0.07 0.1
Total Ranking TTM # 92 # 0 # 0 # 0 # 0
Seq. Equity TTM Growth 0 % 0 % 0 % 358.81 % 0 %
Seq. Total Liabilities TTM Growth 0 % 0 % 0 % 107.44 % 0 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to repayements of liabilities of 0% Immuron Limited decreased Leverage Ratio in the IV. Quarter to 0.04, a new company low.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 15 other companies have achieved lower Leverage Ratio than Immuron Limited. While total ranking remained unchanged compare to previous quarter at no. 92.

Explain Leverage Ratio?
Who are IMRN Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 30
Within the Market # 92


TTM Leverage Ratio Statistics
High Average Low
0.16 0.1 0.04
(Jun 30 2019)   (Jun 30 2021)




Companies with similar Leverage Ratio in the quarter ending Jun 30 2021, within Major Pharmaceutical Preparations Industry Leverage RatioJun 30 2021 MRQ Total LiabilitiesJun 30 2021 MRQ Equity
Annexon Inc   0.12 $ 36.199  Millions$ 295.335  Millions
Ngm Biopharmaceuticals Inc   0.12 $ 44.973  Millions$ 373.075  Millions
Landos Biopharma Inc   0.12 $ 12.679  Millions$ 105.612  Millions
Sierra Oncology Inc   0.12 $ 10.111  Millions$ 84.266  Millions
Immunic Inc   0.12 $ 14.487  Millions$ 120.742  Millions
Zynerba Pharmaceuticals Inc   0.12 $ 10.497  Millions$ 87.699  Millions
Ocuphire Pharma Inc   0.12 $ 2.699  Millions$ 22.553  Millions
Immutep Limited  0.12 $ 8.759  Millions$ 73.272  Millions
Enlivex Therapeutics Ltd   0.12 $ 9.994  Millions$ 85.039  Millions
9 Meters Biopharma Inc   0.12 $ 6.857  Millions$ 59.138  Millions
Imara inc   0.12 $ 7.501  Millions$ 64.967  Millions
Kronos Bio Inc   0.11 $ 47.635  Millions$ 424.107  Millions
Glycomimetics Inc   0.11 $ 12.092  Millions$ 112.286  Millions
Y mabs Therapeutics inc   0.11 $ 25.163  Millions$ 234.316  Millions
Catalyst Pharmaceuticals Inc   0.11 $ 20.186  Millions$ 188.944  Millions
Matinas Biopharma Holdings Inc   0.11 $ 6.689  Millions$ 62.904  Millions
Anaptysbio inc  0.11 $ 40.838  Millions$ 385.731  Millions
Arvinas Inc   0.10 $ 61.080  Millions$ 582.947  Millions
Moleculin Biotech Inc   0.10 $ 8.834  Millions$ 84.700  Millions
Rhythm Pharmaceuticals inc   0.10 $ 36.131  Millions$ 351.689  Millions
Assembly Biosciences Inc   0.10 $ 23.618  Millions$ 231.794  Millions
Morphic Holding inc   0.10 $ 34.912  Millions$ 347.909  Millions
Centessa Pharmaceuticals Plc  0.10 $ 58.115  Millions$ 585.642  Millions
Prometheus Biosciences Inc   0.10 $ 28.003  Millions$ 282.428  Millions
Avidity Biosciences Inc   0.10 $ 26.043  Millions$ 264.480  Millions
Phio Pharmaceuticals Corp   0.10 $ 2.812  Millions$ 28.845  Millions
Xenetic Biosciences Inc   0.10 $ 0.966  Millions$ 9.949  Millions
Aldeyra Therapeutics Inc   0.10 $ 22.629  Millions$ 233.680  Millions
Vanda Pharmaceuticals Inc   0.10 $ 46.224  Millions$ 481.220  Millions
Rocket Pharmaceuticals Inc   0.09 $ 45.717  Millions$ 489.437  Millions

Date modified: 2022-09-10T12:54:21+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ADMEN's Profile

Stock Price

ADMEN's Financials

Business Description

Fundamentals

Charts & Quotes

ADMEN's News

Suppliers

ADMEN's Competitors

Customers & Markets

Economic Indicators

ADMEN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071